%0 Journal Article %A Batista Araújo, Max Roberto %A Bernardes Sousa, Mireille Ângela %A Seabra, Luisa Ferreira %A Caldeira, Letícia Aparecida %A Faria, Carmem Dolores %A Bokermann, Sérgio %A Sant’Anna, Lincoln Oliveira %A dos Santos, Louisy Sanches %A Mattos-Guaraldi, Ana Luíza %T Cutaneous infection by non-diphtheria-toxin producing and penicillin-resistant Corynebacterium diphtheriae strain in a patient with diabetes mellitus %D 2021 %J Access Microbiology, %V 3 %N 11 %@ 2516-8290 %C 000284 %R https://doi.org/10.1099/acmi.0.000284 %K MALDI-TOF MS %K Corynebacterium diphtheriae %K diphtheria toxin %K cutaneous diphtheria %K diabetes %K penicillin-resistance %I Microbiology Society, %X Diphtheria is a potentially fatal infection, mostly caused by diphtheria toxin (DT)-producing Corynebacterium diphtheriae strains. During the last decades, the isolation of DT-producing C. diphtheriae strains has been decreasing worldwide. However, non-DT-producing C. diphtheriae strains emerged as causative agents of cutaneous and invasive infections. Although endemic in countries with warm climates, cutaneous diphtheria is rarely reported in Brazil. Presently, an unusual case of skin lesion in a Brazilian elderly diabetic patient infected by a penicillin-resistant non-DT-producing C. diphtheriae strain was reported. Laboratory diagnosis included mass spectrometry and multiplex PCR analyses. Since cutaneous diphtheria lesions are possible sources of secondary diphtheria cases and systemic diseases and considering that penicillin is the first line of antimicrobial agent for the treatment of these infections, the detection of penicillin-resistant strains of diphtheria bacilli should be a matter of concern. Thus, cases similar to the presently reported should be appropriately investigated and treated, particularly in patients with risk factor (s) for the development of C. diphtheriae invasive infections, such as diabetes. Moreover, health professionals must be aware of the presence of C. diphtheriae in cutaneous lesions of lower limbs, a common type of morbidity in diabetic patients, especially in tropical and subtropical countries. %U https://www.microbiologyresearch.org/content/journal/acmi/10.1099/acmi.0.000284